Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico

@article{BautistaArredondo2006EconomicIO,
  title={Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico},
  author={Sergio Bautista-Arredondo and Aditya Mane and Stefano Michele Bertozzi},
  journal={AIDS},
  year={2006},
  volume={20},
  pages={101–109}
}
Background:Mexico started scaling-up access to antiretroviral treatment in the late 1990s. Even though the Mexican Health System enrolled patients at impressive speed, in the initial years important aspects of the quality of care were overlooked. Objective:To describe antiretroviral prescribing and adherence practices in Mexico during initial scaling-up of antiretroviral treatment in comparison to national treatment guidelines and to estimate the associated economic cost. Methods:Eleven public… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS, ESTIMATED 45% COVERAGE

FILTER CITATIONS BY YEAR

2006
2020

CITATION STATISTICS

  • 1 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Adherence to Long-Term Therapies: Evidence for Action

  • Sabina De Geest, Eduardo Pérez Sabaté
  • Medicine
  • European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
  • 2003

December 2003

VIEW 2 EXCERPTS

A trial comparing nucleoside mono therapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter

  • SM Hammer, DA Katzenstein, +3 authors RH Haubrich
  • N Engl J Med
  • 1996
VIEW 1 EXCERPT

AIDS Issue Briefs

  • 2004